<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-07-19" modified="2017-05-10" version="164">
<accession>Q9NWZ3</accession>
<accession>Q69FE1</accession>
<accession>Q8TDF7</accession>
<accession>Q9Y589</accession>
<name>IRAK4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-associated kinase 4</fullName>
<shortName>IRAK-4</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Renal carcinoma antigen NY-REN-64</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IRAK4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5567" last="5572">
<title>IRAK4: a novel member of the IRAK family with the properties of an IRAK-kinase.</title>
<authorList>
<person name="Li S."/>
<person name="Strelow A."/>
<person name="Fontana E.J."/>
<person name="Wesche H."/>
</authorList>
<dbReference type="PubMed" id="11960013"/>
<dbReference type="DOI" id="10.1073/pnas.082100399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IRAK1 AND TRAF6</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
<title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gordan J.D."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Bander N.H."/>
<person name="Jongeneel C.V."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Jaeger E."/>
<person name="Knuth A."/>
<person name="Chen Y.-T."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="10508479"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19991112)83:4&lt;456::AID-IJC4>3.0.CO;2-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<title>Human interleukin-1 receptor associated kinase 4 cDNA sequences.</title>
<authorList>
<person name="Chuang T.H."/>
<person name="Ulevitch R.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2002-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ARG-98; ARG-390 AND THR-428</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
<title>The finished DNA sequence of human chromosome 12.</title>
<authorList>
<person name="Scherer S.E."/>
<person name="Muzny D.M."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Montgomery K.T."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Lovering R.C."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Draper H."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Havlak P."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Li L."/>
<person name="Li Z."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Plopper F.J.H."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Allen C.C."/>
<person name="Amin A.G."/>
<person name="Anyalebechi V."/>
<person name="Bailey M."/>
<person name="Barbaria J.A."/>
<person name="Bimage K.E."/>
<person name="Bryant N.P."/>
<person name="Burch P.E."/>
<person name="Burkett C.E."/>
<person name="Burrell K.L."/>
<person name="Calderon E."/>
<person name="Cardenas V."/>
<person name="Carter K."/>
<person name="Casias K."/>
<person name="Cavazos I."/>
<person name="Cavazos S.R."/>
<person name="Ceasar H."/>
<person name="Chacko J."/>
<person name="Chan S.N."/>
<person name="Chavez D."/>
<person name="Christopoulos C."/>
<person name="Chu J."/>
<person name="Cockrell R."/>
<person name="Cox C.D."/>
<person name="Dang M."/>
<person name="Dathorne S.R."/>
<person name="David R."/>
<person name="Davis C.M."/>
<person name="Davy-Carroll L."/>
<person name="Deshazo D.R."/>
<person name="Donlin J.E."/>
<person name="D'Souza L."/>
<person name="Eaves K.A."/>
<person name="Egan A."/>
<person name="Emery-Cohen A.J."/>
<person name="Escotto M."/>
<person name="Flagg N."/>
<person name="Forbes L.D."/>
<person name="Gabisi A.M."/>
<person name="Garza M."/>
<person name="Hamilton C."/>
<person name="Henderson N."/>
<person name="Hernandez O."/>
<person name="Hines S."/>
<person name="Hogues M.E."/>
<person name="Huang M."/>
<person name="Idlebird D.G."/>
<person name="Johnson R."/>
<person name="Jolivet A."/>
<person name="Jones S."/>
<person name="Kagan R."/>
<person name="King L.M."/>
<person name="Leal B."/>
<person name="Lebow H."/>
<person name="Lee S."/>
<person name="LeVan J.M."/>
<person name="Lewis L.C."/>
<person name="London P."/>
<person name="Lorensuhewa L.M."/>
<person name="Loulseged H."/>
<person name="Lovett D.A."/>
<person name="Lucier A."/>
<person name="Lucier R.L."/>
<person name="Ma J."/>
<person name="Madu R.C."/>
<person name="Mapua P."/>
<person name="Martindale A.D."/>
<person name="Martinez E."/>
<person name="Massey E."/>
<person name="Mawhiney S."/>
<person name="Meador M.G."/>
<person name="Mendez S."/>
<person name="Mercado C."/>
<person name="Mercado I.C."/>
<person name="Merritt C.E."/>
<person name="Miner Z.L."/>
<person name="Minja E."/>
<person name="Mitchell T."/>
<person name="Mohabbat F."/>
<person name="Mohabbat K."/>
<person name="Montgomery B."/>
<person name="Moore N."/>
<person name="Morris S."/>
<person name="Munidasa M."/>
<person name="Ngo R.N."/>
<person name="Nguyen N.B."/>
<person name="Nickerson E."/>
<person name="Nwaokelemeh O.O."/>
<person name="Nwokenkwo S."/>
<person name="Obregon M."/>
<person name="Oguh M."/>
<person name="Oragunye N."/>
<person name="Oviedo R.J."/>
<person name="Parish B.J."/>
<person name="Parker D.N."/>
<person name="Parrish J."/>
<person name="Parks K.L."/>
<person name="Paul H.A."/>
<person name="Payton B.A."/>
<person name="Perez A."/>
<person name="Perrin W."/>
<person name="Pickens A."/>
<person name="Primus E.L."/>
<person name="Pu L.-L."/>
<person name="Puazo M."/>
<person name="Quiles M.M."/>
<person name="Quiroz J.B."/>
<person name="Rabata D."/>
<person name="Reeves K."/>
<person name="Ruiz S.J."/>
<person name="Shao H."/>
<person name="Sisson I."/>
<person name="Sonaike T."/>
<person name="Sorelle R.P."/>
<person name="Sutton A.E."/>
<person name="Svatek A.F."/>
<person name="Svetz L.A."/>
<person name="Tamerisa K.S."/>
<person name="Taylor T.R."/>
<person name="Teague B."/>
<person name="Thomas N."/>
<person name="Thorn R.D."/>
<person name="Trejos Z.Y."/>
<person name="Trevino B.K."/>
<person name="Ukegbu O.N."/>
<person name="Urban J.B."/>
<person name="Vasquez L.I."/>
<person name="Vera V.A."/>
<person name="Villasana D.M."/>
<person name="Wang L."/>
<person name="Ward-Moore S."/>
<person name="Warren J.T."/>
<person name="Wei X."/>
<person name="White F."/>
<person name="Williamson A.L."/>
<person name="Wleczyk R."/>
<person name="Wooden H.S."/>
<person name="Wooden S.H."/>
<person name="Yen J."/>
<person name="Yoon L."/>
<person name="Yoon V."/>
<person name="Zorrilla S.E."/>
<person name="Nelson D."/>
<person name="Kucherlapati R."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16541075"/>
<dbReference type="DOI" id="10.1038/nature04569"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="10952" last="10956">
<title>Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.</title>
<authorList>
<person name="Jiang Z."/>
<person name="Johnson H.J."/>
<person name="Nie H."/>
<person name="Qin J."/>
<person name="Bird T.A."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="12496252"/>
<dbReference type="DOI" id="10.1074/jbc.M212112200"/>
</citation>
<scope>INTERACTION WITH IRAK1; PELI1 AND TRAF6</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="197" first="263" last="268">
<title>Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.</title>
<authorList>
<person name="Burns K."/>
<person name="Janssens S."/>
<person name="Brissoni B."/>
<person name="Olivos N."/>
<person name="Beyaert R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="12538665"/>
<dbReference type="DOI" id="10.1084/jem.20021790"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF IRAK1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="198" first="521" last="531">
<title>Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections.</title>
<authorList>
<person name="Medvedev A.E."/>
<person name="Lentschat A."/>
<person name="Kuhns D.B."/>
<person name="Blanco J.C.G."/>
<person name="Salkowski C."/>
<person name="Zhang S."/>
<person name="Arditi M."/>
<person name="Gallin J.I."/>
<person name="Vogel S.N."/>
</authorList>
<dbReference type="PubMed" id="12925671"/>
<dbReference type="DOI" id="10.1084/jem.20030701"/>
</citation>
<scope>INVOLVEMENT IN IRAK4D</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="26748" last="26753">
<title>IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.</title>
<authorList>
<person name="Qin J."/>
<person name="Jiang Z."/>
<person name="Qian Y."/>
<person name="Casanova J.-L."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="15084582"/>
<dbReference type="DOI" id="10.1074/jbc.M400785200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-213</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Science" volume="299" first="2076" last="2079">
<title>Pyogenic bacterial infections in humans with IRAK-4 deficiency.</title>
<authorList>
<person name="Picard C."/>
<person name="Puel A."/>
<person name="Bonnet M."/>
<person name="Ku C.-L."/>
<person name="Bustamante J."/>
<person name="Yang K."/>
<person name="Soudais C."/>
<person name="Dupuis S."/>
<person name="Feinberg J."/>
<person name="Fieschi C."/>
<person name="Elbim C."/>
<person name="Hitchcock R."/>
<person name="Lammas D."/>
<person name="Davies G."/>
<person name="Al-Ghonaium A."/>
<person name="Al-Rayes H."/>
<person name="Al-Jumaah S."/>
<person name="Al-Hajjar S."/>
<person name="Al-Mohsen I.Z."/>
<person name="Frayha H.H."/>
<person name="Rucker R."/>
<person name="Hawn T.R."/>
<person name="Aderem A."/>
<person name="Tufenkeji H."/>
<person name="Haraguchi S."/>
<person name="Day N.K."/>
<person name="Good R.A."/>
<person name="Gougerot-Pocidalo M.-A."/>
<person name="Ozinsky A."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="12637671"/>
<dbReference type="DOI" id="10.1126/science.1081902"/>
</citation>
<scope>INVOLVEMENT IN IRAK4D</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Immunity" volume="23" first="479" last="490">
<title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST 2 and induces T helper type 2-associated cytokines.</title>
<authorList>
<person name="Schmitz J."/>
<person name="Owyang A."/>
<person name="Oldham E."/>
<person name="Song Y."/>
<person name="Murphy E."/>
<person name="McClanahan T.K."/>
<person name="Zurawski G."/>
<person name="Moshrefi M."/>
<person name="Qin J."/>
<person name="Li X."/>
<person name="Gorman D.M."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="16286016"/>
<dbReference type="DOI" id="10.1016/j.immuni.2005.09.015"/>
</citation>
<scope>INTERACTION WITH IL1RL1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="1057" last="1065">
<title>Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1.</title>
<authorList>
<person name="Choi K.C."/>
<person name="Lee Y.S."/>
<person name="Lim S."/>
<person name="Choi H.K."/>
<person name="Lee C.H."/>
<person name="Lee E.K."/>
<person name="Hong S."/>
<person name="Kim I.H."/>
<person name="Kim S.J."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="16951688"/>
<dbReference type="DOI" id="10.1038/ni1383"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH IRAK1; MYD88; PELI1 AND TRAF6</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Biochem. J." volume="403" first="451" last="461">
<title>Cross-talk between IRAK-4 and the NADPH oxidase.</title>
<authorList>
<person name="Pacquelet S."/>
<person name="Johnson J.L."/>
<person name="Ellis B.A."/>
<person name="Brzezinska A.A."/>
<person name="Lane W.S."/>
<person name="Munafo D.B."/>
<person name="Catz S.D."/>
</authorList>
<dbReference type="PubMed" id="17217339"/>
<dbReference type="DOI" id="10.1042/BJ20061184"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NCF1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="13552" last="13560">
<title>IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression.</title>
<authorList>
<person name="Koziczak-Holbro M."/>
<person name="Joyce C."/>
<person name="Gluck A."/>
<person name="Kinzel B."/>
<person name="Muller M."/>
<person name="Tschopp C."/>
<person name="Mathison J.C."/>
<person name="Davis C.N."/>
<person name="Gram H."/>
</authorList>
<dbReference type="PubMed" id="17337443"/>
<dbReference type="DOI" id="10.1074/jbc.M700548200"/>
</citation>
<scope>FUNCTION IN TLR7 SIGNALING PATHWAY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Med. Genet." volume="44" first="16" last="23">
<title>IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.</title>
<authorList>
<person name="Ku C.-L."/>
<person name="Picard C."/>
<person name="Erdos M."/>
<person name="Jeurissen A."/>
<person name="Bustamante J."/>
<person name="Puel A."/>
<person name="von Bernuth H."/>
<person name="Filipe-Santos O."/>
<person name="Chang H.-H."/>
<person name="Lawrence T."/>
<person name="Raes M."/>
<person name="Marodi L."/>
<person name="Bossuyt X."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="16950813"/>
<dbReference type="DOI" id="10.1136/jmg.2006.044446"/>
</citation>
<scope>INVOLVEMENT IN IPD1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="43" last="52">
<title>The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.</title>
<authorList>
<person name="Ordureau A."/>
<person name="Smith H."/>
<person name="Windheim M."/>
<person name="Peggie M."/>
<person name="Carrick E."/>
<person name="Morrice N."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="17997719"/>
<dbReference type="DOI" id="10.1042/BJ20071365"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PELI1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-34</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="18276" last="18282">
<title>IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).</title>
<authorList>
<person name="Dunne A."/>
<person name="Carpenter S."/>
<person name="Brikos C."/>
<person name="Gray P."/>
<person name="Strelow A."/>
<person name="Wesche H."/>
<person name="Morrice N."/>
<person name="O'Neill L.A."/>
</authorList>
<dbReference type="PubMed" id="20400509"/>
<dbReference type="DOI" id="10.1074/jbc.M109.098137"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TIRAP</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="11875" last="11882">
<title>Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes.</title>
<authorList>
<person name="Nagpal K."/>
<person name="Plantinga T.S."/>
<person name="Sirois C.M."/>
<person name="Monks B.G."/>
<person name="Latz E."/>
<person name="Netea M.G."/>
<person name="Golenbock D.T."/>
</authorList>
<dbReference type="PubMed" id="21325272"/>
<dbReference type="DOI" id="10.1074/jbc.M110.199653"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Trends Immunol." volume="32" first="104" last="109">
<title>What the Myddosome structure tells us about the initiation of innate immunity.</title>
<authorList>
<person name="Gay N.J."/>
<person name="Gangloff M."/>
<person name="O'Neill L.A."/>
</authorList>
<dbReference type="PubMed" id="21269878"/>
<dbReference type="DOI" id="10.1016/j.it.2010.12.005"/>
</citation>
<scope>REVIEW ON MYDDOSOME</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Structure" volume="14" first="1835" last="1844">
<title>Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper.</title>
<authorList>
<person name="Wang Z."/>
<person name="Liu J."/>
<person name="Sudom A."/>
<person name="Ayres M."/>
<person name="Li S."/>
<person name="Wesche H."/>
<person name="Powers J.P."/>
<person name="Walker N.P.C."/>
</authorList>
<dbReference type="PubMed" id="17161373"/>
<dbReference type="DOI" id="10.1016/j.str.2006.11.001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 154-460 IN COMPLEX WITH INHIBITORS</scope>
<scope>PHOSPHORYLATION AT THR-345 AND SER-346</scope>
</reference>
<reference key="31">
<citation type="submission" date="2006-12" db="PDB data bank">
<title>Crystal structures of the apo and inhibited IRAK4 kinase domain.</title>
<authorList>
<person name="Mol C.D."/>
<person name="Arduini R.M."/>
<person name="Baker D.P."/>
<person name="Chien E.Y."/>
<person name="Dougan D.R."/>
<person name="Friedman J."/>
<person name="Gibaja V."/>
<person name="Hession C.A."/>
<person name="Horne A."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 163-460</scope>
<scope>PHOSPHORYLATION AT THR-342 AND THR-345</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Immunol." volume="178" first="2641" last="2645">
<title>Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations.</title>
<authorList>
<person name="Kuglstatter A."/>
<person name="Villasenor A.G."/>
<person name="Shaw D."/>
<person name="Lee S.W."/>
<person name="Tsing S."/>
<person name="Niu L."/>
<person name="Song K.W."/>
<person name="Barnett J.W."/>
<person name="Browner M.F."/>
</authorList>
<dbReference type="PubMed" id="17312103"/>
<dbReference type="DOI" id="10.4049/jimmunol.178.5.2641"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 160-460 IN COMPLEX WITH ATP ANALOGS</scope>
<scope>PHOSPHORYLATION AT THR-342; THR-345 AND SER-346</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Nature" volume="465" first="885" last="890">
<title>Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.</title>
<authorList>
<person name="Lin S.-C."/>
<person name="Lo Y.-C."/>
<person name="Wu H."/>
</authorList>
<dbReference type="PubMed" id="20485341"/>
<dbReference type="DOI" id="10.1038/nature09121"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 4-106</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="J. Immunol." volume="179" first="4754" last="4765">
<title>TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway.</title>
<authorList>
<person name="Hoarau C."/>
<person name="Gerard B."/>
<person name="Lescanne E."/>
<person name="Henry D."/>
<person name="Francois S."/>
<person name="Lacapere J.J."/>
<person name="El Benna J."/>
<person name="Dang P.M."/>
<person name="Grandchamp B."/>
<person name="Lebranchu Y."/>
<person name="Gougerot-Pocidalo M.A."/>
<person name="Elbim C."/>
</authorList>
<dbReference type="PubMed" id="17878374"/>
<dbReference type="DOI" id="10.4049/jimmunol.179.7.4754"/>
</citation>
<scope>VARIANT IRAK4D CYS-12</scope>
<scope>CHARACTERIZATION OF VARIANT IRAK4D CYS-12</scope>
<scope>VARIANT HIS-391</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-5; VAL-355; HIS-391 AND THR-428</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Br. J. Haematol." volume="147" first="153" last="156">
<title>Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency.</title>
<authorList>
<person name="Bouma G."/>
<person name="Doffinger R."/>
<person name="Patel S.Y."/>
<person name="Peskett E."/>
<person name="Sinclair J.C."/>
<person name="Barcenas-Morales G."/>
<person name="Cerron-Gutierrez L."/>
<person name="Kumararatne D.S."/>
<person name="Davies E.G."/>
<person name="Thrasher A.J."/>
<person name="Burns S.O."/>
</authorList>
<dbReference type="PubMed" id="19663824"/>
<dbReference type="DOI" id="10.1111/j.1365-2141.2009.07838.x"/>
</citation>
<scope>VARIANT IRAK4D ASP-298</scope>
<scope>CHARACTERIZATION OF VARIANT IRAK4D ASP-298</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Medicine (Baltimore)" volume="89" first="403" last="425">
<title>Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.</title>
<authorList>
<person name="Picard C."/>
<person name="von Bernuth H."/>
<person name="Ghandil P."/>
<person name="Chrabieh M."/>
<person name="Levy O."/>
<person name="Arkwright P.D."/>
<person name="McDonald D."/>
<person name="Geha R.S."/>
<person name="Takada H."/>
<person name="Krause J.C."/>
<person name="Creech C.B."/>
<person name="Ku C.L."/>
<person name="Ehl S."/>
<person name="Marodi L."/>
<person name="Al-Muhsen S."/>
<person name="Al-Hajjar S."/>
<person name="Al-Ghonaium A."/>
<person name="Day-Good N.K."/>
<person name="Holland S.M."/>
<person name="Gallin J.I."/>
<person name="Chapel H."/>
<person name="Speert D.P."/>
<person name="Rodriguez-Gallego C."/>
<person name="Colino E."/>
<person name="Garty B.Z."/>
<person name="Roifman C."/>
<person name="Hara T."/>
<person name="Yoshikawa H."/>
<person name="Nonoyama S."/>
<person name="Domachowske J."/>
<person name="Issekutz A.C."/>
<person name="Tang M."/>
<person name="Smart J."/>
<person name="Zitnik S.E."/>
<person name="Hoarau C."/>
<person name="Kumararatne D.S."/>
<person name="Thrasher A.J."/>
<person name="Davies E.G."/>
<person name="Bethune C."/>
<person name="Sirvent N."/>
<person name="de Ricaud D."/>
<person name="Camcioglu Y."/>
<person name="Vasconcelos J."/>
<person name="Guedes M."/>
<person name="Vitor A.B."/>
<person name="Rodrigo C."/>
<person name="Almazan F."/>
<person name="Mendez M."/>
<person name="Arostegui J.I."/>
<person name="Alsina L."/>
<person name="Fortuny C."/>
<person name="Reichenbach J."/>
<person name="Verbsky J.W."/>
<person name="Bossuyt X."/>
<person name="Doffinger R."/>
<person name="Abel L."/>
<person name="Puel A."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="21057262"/>
<dbReference type="DOI" id="10.1097/MD.0b013e3181fd8ec3"/>
</citation>
<scope>INVOLVEMENT IN IRAK4D</scope>
<scope>VARIANT IRAK4D ASP-298</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="Mol. Immunol." volume="58" first="66" last="76">
<title>Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.</title>
<authorList>
<person name="Yamamoto T."/>
<person name="Tsutsumi N."/>
<person name="Tochio H."/>
<person name="Ohnishi H."/>
<person name="Kubota K."/>
<person name="Kato Z."/>
<person name="Shirakawa M."/>
<person name="Kondo N."/>
</authorList>
<dbReference type="PubMed" id="24316379"/>
<dbReference type="DOI" id="10.1016/j.molimm.2013.11.008"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS VAL-5; TRP-20; THR-26; VAL-39 AND ARG-98</scope>
<scope>CHARACTERIZATION OF VARIANTS IRAK4D CYS-12 AND ASP-298</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MYD88</scope>
</reference>
<comment type="function">
<text evidence="10 12 15 20 22 24 25 27 30">Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="21">650 uM for ATP (at pH 7.5)</KM>
<KM evidence="21">1100 uM for substrate (at pH 7.5)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="10 11 16 18 19 21 30">Associates with MYD88 and IRAK2 to form a ternary complex called the Myddosome. Once phosphorylated, IRAK4 dissociates from the receptor complex and then associates with the TNF receptor-associated factor 6 (TRAF6), IRAK1, and PELI1; this intermediate complex is required for subsequent NF-kappa-B activation. Direct binding of SMAD6 to PELI1 prevents complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression. Interacts with IL1RL1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448378"/>
<interactant intactId="EBI-646179">
<id>Q8K4B2</id>
<label>Irak3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448378"/>
<interactant intactId="EBI-447677">
<id>Q99836</id>
<label>MYD88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448378"/>
<interactant intactId="EBI-448407">
<id>Q9HAT8</id>
<label>PELI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448378"/>
<interactant intactId="EBI-528644">
<id>P58753</id>
<label>TIRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NWZ3-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NWZ3-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041556"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="8">Phosphorylated.</text>
</comment>
<comment type="disease" evidence="17">
<disease id="DI-02249">
<name>Recurrent isolated invasive pneumococcal disease 1</name>
<acronym>IPD1</acronym>
<description>Recurrent invasive pneumococcal disease (IPD) is defined as two episodes of IPD occurring at least 1 month apart, whether caused by the same or different serotypes or strains. Recurrent IPD occurs in at least 2% of patients in most series, making IPD the most important known risk factor for subsequent IPD.</description>
<dbReference type="MIM" id="610799"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13 14 24 26 28 30">
<disease id="DI-01831">
<name>IRAK4 deficiency</name>
<acronym>IRAK4D</acronym>
<description>Causes extracellular pyogenic bacterial and fungal infections in otherwise healthy children.</description>
<dbReference type="MIM" id="607676"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. Pelle subfamily.</text>
</comment>
<comment type="online information" name="IRAK4base">
<link uri="http://structure.bmc.lu.se/idbase/IRAK4base/"/>
<text>IRAK4 mutation db</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/irak4/"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="AF445802">
<property type="protein sequence ID" value="AAM15772.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF155118">
<property type="protein sequence ID" value="AAD42884.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY340964">
<property type="protein sequence ID" value="AAR02360.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY340965">
<property type="protein sequence ID" value="AAR02361.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY340966">
<property type="protein sequence ID" value="AAR02362.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY340967">
<property type="protein sequence ID" value="AAR02363.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000528">
<property type="protein sequence ID" value="BAA91232.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK299944">
<property type="protein sequence ID" value="BAG61774.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY186092">
<property type="protein sequence ID" value="AAN75440.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC093012">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013316">
<property type="protein sequence ID" value="AAH13316.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44862.1">
<molecule id="Q9NWZ3-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8744.1">
<molecule id="Q9NWZ3-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001107654.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="NM_001114182.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138728.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="NM_001145256.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138729.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="NM_001145257.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138730.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="NM_001145258.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057207.2">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="NM_016123.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269000.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_005268943.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269001.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_005268944.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269002.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_005268945.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269004.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="XM_005268947.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269005.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="XM_005268948.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005269006.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="XM_005268949.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006719501.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_006719438.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006719502.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="XM_006719439.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011536733.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_011538431.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011536734.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_011538432.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011536735.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_011538433.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016874879.1">
<molecule id="Q9NWZ3-1"/>
<property type="nucleotide sequence ID" value="XM_017019390.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016874880.1">
<molecule id="Q9NWZ3-2"/>
<property type="nucleotide sequence ID" value="XM_017019391.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.138499"/>
<dbReference type="PDB" id="2NRU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=154-460"/>
</dbReference>
<dbReference type="PDB" id="2NRY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B/C/D=154-460"/>
</dbReference>
<dbReference type="PDB" id="2O8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=163-460"/>
</dbReference>
<dbReference type="PDB" id="2OIB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="2OIC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="2OID">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="3MOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="G/H/I/J=4-106"/>
</dbReference>
<dbReference type="PDB" id="4RMZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=154-460"/>
</dbReference>
<dbReference type="PDB" id="4U97">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=154-460"/>
</dbReference>
<dbReference type="PDB" id="4U9A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=154-460"/>
</dbReference>
<dbReference type="PDB" id="4XS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4Y73">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.14"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4YO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.32"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4YP8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4ZTL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4ZTM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="4ZTN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDB" id="5KX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=160-460"/>
</dbReference>
<dbReference type="PDB" id="5KX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.67"/>
<property type="chains" value="A/B/C/D=160-460"/>
</dbReference>
<dbReference type="PDBsum" id="2NRU"/>
<dbReference type="PDBsum" id="2NRY"/>
<dbReference type="PDBsum" id="2O8Y"/>
<dbReference type="PDBsum" id="2OIB"/>
<dbReference type="PDBsum" id="2OIC"/>
<dbReference type="PDBsum" id="2OID"/>
<dbReference type="PDBsum" id="3MOP"/>
<dbReference type="PDBsum" id="4RMZ"/>
<dbReference type="PDBsum" id="4U97"/>
<dbReference type="PDBsum" id="4U9A"/>
<dbReference type="PDBsum" id="4XS2"/>
<dbReference type="PDBsum" id="4Y73"/>
<dbReference type="PDBsum" id="4YO6"/>
<dbReference type="PDBsum" id="4YP8"/>
<dbReference type="PDBsum" id="4ZTL"/>
<dbReference type="PDBsum" id="4ZTM"/>
<dbReference type="PDBsum" id="4ZTN"/>
<dbReference type="PDBsum" id="5KX7"/>
<dbReference type="PDBsum" id="5KX8"/>
<dbReference type="ProteinModelPortal" id="Q9NWZ3"/>
<dbReference type="SMR" id="Q9NWZ3"/>
<dbReference type="BioGrid" id="119322">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="DIP" id="DIP-31351N"/>
<dbReference type="IntAct" id="Q9NWZ3">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-1383671"/>
<dbReference type="STRING" id="9606.ENSP00000390651"/>
<dbReference type="BindingDB" id="Q9NWZ3"/>
<dbReference type="ChEMBL" id="CHEMBL3778"/>
<dbReference type="DrugBank" id="DB08590">
<property type="generic name" value="1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2045"/>
<dbReference type="iPTMnet" id="Q9NWZ3"/>
<dbReference type="PhosphoSitePlus" id="Q9NWZ3"/>
<dbReference type="BioMuta" id="IRAK4"/>
<dbReference type="DMDM" id="50401181"/>
<dbReference type="EPD" id="Q9NWZ3"/>
<dbReference type="MaxQB" id="Q9NWZ3"/>
<dbReference type="PaxDb" id="Q9NWZ3"/>
<dbReference type="PeptideAtlas" id="Q9NWZ3"/>
<dbReference type="PRIDE" id="Q9NWZ3"/>
<dbReference type="DNASU" id="51135"/>
<dbReference type="Ensembl" id="ENST00000431837">
<molecule id="Q9NWZ3-2"/>
<property type="protein sequence ID" value="ENSP00000390327"/>
<property type="gene ID" value="ENSG00000198001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000440781">
<molecule id="Q9NWZ3-2"/>
<property type="protein sequence ID" value="ENSP00000408734"/>
<property type="gene ID" value="ENSG00000198001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000551736">
<molecule id="Q9NWZ3-1"/>
<property type="protein sequence ID" value="ENSP00000446490"/>
<property type="gene ID" value="ENSG00000198001"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000613694">
<molecule id="Q9NWZ3-1"/>
<property type="protein sequence ID" value="ENSP00000479889"/>
<property type="gene ID" value="ENSG00000198001"/>
</dbReference>
<dbReference type="GeneID" id="51135"/>
<dbReference type="KEGG" id="hsa:51135"/>
<dbReference type="UCSC" id="uc001rnt.4">
<molecule id="Q9NWZ3-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="51135"/>
<dbReference type="DisGeNET" id="51135"/>
<dbReference type="GeneCards" id="IRAK4"/>
<dbReference type="HGNC" id="HGNC:17967">
<property type="gene designation" value="IRAK4"/>
</dbReference>
<dbReference type="HPA" id="CAB016685"/>
<dbReference type="HPA" id="CAB022077"/>
<dbReference type="MalaCards" id="IRAK4"/>
<dbReference type="MIM" id="606883">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="607676">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="610799">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NWZ3"/>
<dbReference type="OpenTargets" id="ENSG00000198001"/>
<dbReference type="Orphanet" id="70592">
<property type="disease" value="Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134914577"/>
<dbReference type="eggNOG" id="KOG1187">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063073"/>
<dbReference type="HOGENOM" id="HOG000116550"/>
<dbReference type="HOVERGEN" id="HBG066836"/>
<dbReference type="InParanoid" id="Q9NWZ3"/>
<dbReference type="KO" id="K04733"/>
<dbReference type="OMA" id="LAKCQHE"/>
<dbReference type="OrthoDB" id="EOG091G0YKT"/>
<dbReference type="PhylomeDB" id="Q9NWZ3"/>
<dbReference type="TreeFam" id="TF351380"/>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:Mal cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602680">
<property type="pathway name" value="MyD88 deficiency (TLR5)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603037">
<property type="pathway name" value="IRAK4 deficiency (TLR5)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975110">
<property type="pathway name" value="TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975138">
<property type="pathway name" value="TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975155">
<property type="pathway name" value="MyD88 dependent cascade initiated on endosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975871">
<property type="pathway name" value="MyD88 cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="SignaLink" id="Q9NWZ3"/>
<dbReference type="SIGNOR" id="Q9NWZ3"/>
<dbReference type="ChiTaRS" id="IRAK4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9NWZ3"/>
<dbReference type="GenomeRNAi" id="51135"/>
<dbReference type="PRO" id="PR:Q9NWZ3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000198001"/>
<dbReference type="CleanEx" id="HS_IRAK4"/>
<dbReference type="ExpressionAtlas" id="Q9NWZ3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NWZ3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005149">
<property type="term" value="F:interleukin-1 receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001816">
<property type="term" value="P:cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002446">
<property type="term" value="P:neutrophil mediated immunity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990266">
<property type="term" value="P:neutrophil migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034162">
<property type="term" value="P:toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017428">
<property type="entry name" value="IL-1_rcpt-assoc_kin4"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038189">
<property type="entry name" value="IRAK4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Interleukin-1 receptor-associated kinase 4" id="PRO_0000086035">
<location>
<begin position="1"/>
<end position="460"/>
</location>
</feature>
<feature type="domain" description="Death">
<location>
<begin position="20"/>
<end position="104"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="186"/>
<end position="454"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="192"/>
<end position="200"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="313"/>
<end position="316"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="9">
<location>
<position position="311"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="213"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="329"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="21 31">
<location>
<position position="342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="19 21 31">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19 21">
<location>
<position position="346"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041556" evidence="33 34">
<location>
<begin position="1"/>
<end position="124"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs56312115." id="VAR_040588" evidence="23 30">
<original>I</original>
<variation>V</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In IRAK4D; no effect on inhibition of NF-kappa-B complex activation; loss of interaction with MYD88; decreases protein stability; dbSNP:rs377584435." id="VAR_072888" evidence="24 30">
<original>R</original>
<variation>C</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; increases inhibition of NF-kappa-B complex activation; decreases interaction with MYD88; decreases protein stability; dbSNP:rs143625818." id="VAR_072889" evidence="30">
<original>R</original>
<variation>W</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs138116867." id="VAR_072890" evidence="30">
<original>I</original>
<variation>T</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs113588409." id="VAR_072891" evidence="30">
<original>I</original>
<variation>V</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs4251469." id="VAR_019354" evidence="30 32">
<original>S</original>
<variation>R</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In IRAK4D; decreases inhibition of NF-kappa-B complex activation; impairs neutrophil migration and phagocytosis; dbSNP:rs568782766." id="VAR_072892" evidence="26 28 30">
<original>G</original>
<variation>D</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs142376871." id="VAR_040589" evidence="23">
<original>M</original>
<variation>V</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4251583." id="VAR_019355" evidence="32">
<original>H</original>
<variation>R</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with IRAK4D in association with C-12; probable neutral polymorphism; dbSNP:rs55944915." id="VAR_040590" evidence="23 24">
<original>R</original>
<variation>H</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4251545." id="VAR_019356" evidence="23 32">
<original>A</original>
<variation>T</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="15">
<original>K</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAM15772." ref="1" evidence="35">
<original>V</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD42884." ref="2" evidence="35">
<original>V</original>
<variation>G</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD42884." ref="2" evidence="35">
<original>L</original>
<variation>R</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD42884." ref="2" evidence="35">
<original>R</original>
<variation>S</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD42884." ref="2" evidence="35">
<original>Q</original>
<variation>H</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="11"/>
<end position="13"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="16"/>
<end position="26"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="31"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="42"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="66"/>
<end position="73"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="74"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="81"/>
<end position="89"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="90"/>
<end position="92"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="170"/>
<end position="176"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="177"/>
<end position="180"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="185"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="209"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="226"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="248"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="259"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="270"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="285"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="357"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="367"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="395"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="398"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="410"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="423"/>
<end position="436"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="441"/>
<end position="443"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="447"/>
<end position="457"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NRU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OIB"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MOP"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4U97"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Y73"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11960013"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12496252"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12538665"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12637671"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12925671"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084582"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286016"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16950813"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951688"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17161373"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17217339"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17312103"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17337443"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17878374"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997719"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19663824"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20400509"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21057262"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21325272"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316379"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="31"/>
</evidence>
<evidence key="32" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<sequence length="460" mass="51530" checksum="6C8156ADF25FF81E" modified="2000-10-01" version="1">
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALL
QTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITV
QQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNF
DERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC
QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN
FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL
RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND
ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>